EP: 17.Treatment Advances in HR+ Breast Cancer Sara Hurvitz, MD: Andrew, every patient is different, but how do you approach a low-risk, early-stage hormone receptor-positive breast cancer versus high-risk, nonmetastatic ER-positive breast cancer? Where are areas of unmet need? Andrew Seidma...
(2006) Treatment options for older woman with early breast cancer. Expert Review of Anticancer Therapy 6 , 941-950 /M Myat Moe, T Pwint Pwint, RCF Leonard. (2006) Treatment options for older woman with early breast cancer. Expert Review of Anticancer Therapy 6 , 941-950 /...
Your treatment plan for early breast cancer depends on many factors and is personalized for your needs. But it will take you through some combination of standard treatments to follow-up care. Test what you know about the treatment journey with this quiz. 1/3 If you catch breast cancer ...
At ASCO 2024, Avan J. Armaghani, MD, highlights two key presentations. First, a retrospective study on adjuvant endocrine therapy in ER-low breast cancer (1%-10% ER-positivity) demonstrated that patients who skipped this therapy had significantly worse overall survival, especially those who receiv...
Current status of neoadjuvant endocrine therapy in early stage breast cancer. Curr Treat Options Oncol. 2018;19(5):23. doi: 10.1007/s11864-018-0538-9. Martin M, Hurvitz SA, Chan D, et al. Final results of NeoMONARCH: A phase 2 neoadjuvant study of abemaciclib in postmenopausal women ...
Both incidence of breast cancer and survival have increased in recent years and there is a need to review follow up strategies. This study aims to assess the evidence for benefits of follow-up in different settings for women who have had treatment for early breast cancer. Method A systematic ...
; New technologies in Breast Cancer Diagnosis; Selection of patients for Breast-conserving therapy; Management of the axilla in primary breast cancer or Is sentinel lymph node biopsy useful?; Expanded use of adjuvant systemic therapy; Genetic predisposition for Breast Cancer; Clinical options for ...
BACKGROUND :Patients 65 years old or older with early endocrine-responsive breast cancer have many treatment options, including no radiation. This study aimed to evaluate treatment preference when intraoperative radiation therapy (IORT) is offered in this population. METHODS :The study reviewed patients...
Early breast cancer management in practice In the preceding section, the therapy options for different classes of BC, considering receptor expression, are described. Nonetheless, treatment decisions are not solely dependent on receptor expression due to the associated costs of diagnosis. Consequently, pre...
Wardley A. Capecitabine: Expanding options for the treatment of patients with early or locally advanced breast cancer. Oncologist 2006;11(Suppl 1):20-26.Wardley A. Capecitabine: expanding options for the treatment of patients with early or locally advanced breast cancer. Oncologist 2006; 11: 20-...